Although SMOC1 and SPON1 have been reported to change in AD plasma using antibody- or aptamer-based proteomic technologies [30], members of M42 have been extremely difficult to identify and quantify using mass spectrometry (MS)-based proteomic approaches in plasma. The gene discussed is SMOC1; the disease is Alzheimer disease.